{"id":"W2944341352","doi":"10.1007/s12282-019-00973-4","title":"A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer","year":2019,"lang":"en","type":"review","venue":"Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"AstraZeneca; Amgen","keywords":"Fulvestrant; Medicine; Anastrozole; Internal medicine; Oncology; Odds ratio; Breast cancer; Cancer; Estrogen receptor; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02446287,0.003967247,0.01909352,0.005428392,0.00058947,0.003969024,0.002207384,0.00279096,0.004272168],"category_scores_gemma":[0.04167204,0.001615475,0.08324236,0.004540087,0.0007444602,0.00181883,0.001506511,0.003066367,0.0004780342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002453561,"about_ca_system_score_gemma":0.001617598,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00516034,"about_ca_topic_score_gemma":0.005964712,"domain_scores_codex":[0.9795772,0.01378975,0.002951557,0.002000456,0.001303628,0.0003773749],"domain_scores_gemma":[0.9705174,0.02343562,0.003510512,0.00117789,0.0009905526,0.0003680276],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.008943778,0.00002513843,0.002322618,0.02983602,0.9537957,0.00006313817,0.00001832442,0.001053731,0.0001852241,0.00007951905,0.0002410539,0.003435763],"study_design_scores_gemma":[0.001634116,0.0002758103,0.001574585,0.00140462,0.994002,0.0000404359,0.00001030513,0.0004114467,0.00007133784,0.0001581543,0.0004055553,0.00001146337],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.04056642,0.9505754,0.0035729,0.0006284153,0.000777116,0.0006532282,0.001946354,0.000151266,0.001128828],"genre_scores_gemma":[0.7934388,0.1922873,0.00604232,0.001820907,0.0006586403,0.001952974,0.002545723,0.000136098,0.001117314],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02446287,"threshold_uncertainty_score":0.1293736,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.165354414097557,"score_gpt":0.4697720474355399,"score_spread":0.3044176333379828,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}